Travel medicine statistics show that illness after international travel is shaped by destination, trip length, traveler type, and preparation. In U.S. GeoSentinel data from 2012–2021, acute diarrhea represented 16.9% of diagnoses among nonmigrant travelers, while malaria represented 3.5%. Other studies show that long-term travelers had higher odds of several prolonged or parasitic illnesses, and that many travelers experienced trips that differed from their original plans.
Contents
- What travel-medicine surveillance measures
- Most common diagnoses among travelers
- Fever and malaria statistics
- Pretravel care and vaccination timing
- How trip length changes risk
- Business, leisure, and visiting-friends travelers
- Why planned and actual trips can differ
What travel-medicine surveillance measures
GeoSentinel was established in 1995 as a collaboration between the CDC and the International Society of Travel Medicine. Its surveillance focuses on travelers who cross an international border, distinguishing it from surveillance limited to domestic illness. The 2012–2021 summary included 71 sites and 164 affiliate members.
The network describes illness among people who reach participating clinical sites. It does not represent every traveler. In the U.S. GeoSentinel analysis covering 2012–2021, the total numbers of travelers who did not seek care and ill travelers who sought care outside the network were unknown. That limitation matters when interpreting percentages: these figures describe diagnosed cases in the surveillance population, not the probability that every traveler will develop a condition.
An earlier GeoSentinel summary covered 164,378 patients worldwide from September 1997 through December 2011. Only 40.5% of all ill travelers in that report said they had made a pretravel medical visit. Among travelers visiting friends and relatives, or VFR travelers, only 18.3% had received advice before travel. These figures describe reported care and advice during that period; they should not be treated as independently verified current rates.
Most common diagnoses among travelers
The U.S. GeoSentinel analysis from 2012–2021 provides a useful view of diagnosed illness among nonmigrant travelers. Acute diarrhea was the leading listed diagnosis at 16.9%. Viral syndrome accounted for 4.9%, irritable bowel syndrome for 4.1%, campylobacteriosis for 3.1%, and malaria for 3.5%.
These percentages are not a complete list of all diagnoses, so they should not be added together as if they described the whole population. They instead show the relative position of several conditions within the report’s nonmigrant traveler diagnoses. The pattern also illustrates why travel medicine includes both common gastrointestinal problems and conditions requiring urgent evaluation.
The 2012–2011-era worldwide summary found that acute unspecified diarrhea was among the top two diagnoses for travelers from sub-Saharan Africa, South America, Central America, and the Caribbean. The finding is geographic and historical: it describes the destinations and data period in that surveillance summary, rather than a universal ranking for every itinerary today.
Migrants in the 2012–2021 U.S. report had a different pattern. Their most frequent diagnoses included vitamin D deficiency and latent tuberculosis. This distinction is one reason travel health statistics should not combine migrant and nonmigrant travelers without specifying the population.
Fever and malaria statistics
Among febrile diagnoses in the U.S. GeoSentinel analysis covering 2012–2021, viral syndrome accounted for 29.0%, malaria for 21.0%, dengue for 13.7%, chikungunya for 6.4%, and unspecified febrile illness for 5.0%.
| Febrile diagnosis | Share of febrile diagnoses |
|---|---|
| Viral syndrome | 29.0% |
| Malaria | 21.0% |
| Dengue | 13.7% |
| Chikungunya | 6.4% |
| Unspecified febrile illness | 5.0% |
These are shares within the febrile-diagnosis group, not the share of all travelers. The same report’s 3.5% malaria figure applies to nonmigrant traveler diagnoses overall, so the two percentages use different denominators.
CDC reported 2,048 malaria cases in the United States and its territories in 2019 and 602 cases in 2020. CDC also says that about 2,000 malaria cases are diagnosed in the United States in a typical year, mostly in returned travelers. The CDC Yellow Book 2026 notes that the annual number of U.S. malaria cases reported to CDC increased from 1973 to 2018. These measurements cover different periods and should not be read as one continuous annual series.
CDC advises that travelers to malaria-endemic areas may need one antimalarial regimen along with mosquito-bite prevention measures. For atovaquone-proguanil, prophylaxis should continue daily for 7 days after leaving an endemic area. Mefloquine should begin 1–2 weeks before travel, while primaquine should begin 1–2 days before travel. These are timing recommendations, not estimates of illness risk.
Pretravel care and vaccination timing
Pretravel consultation statistics show both a care gap and a practical planning window. In the 1997–2011 GeoSentinel summary, 40.5% of ill travelers reported a pretravel medical visit. Among VFR travelers, the share reporting advice before travel was 18.3%. The populations and measurement period are important because these figures do not establish current access or current behavior.
CDC says routine vaccination should be provided for all people through age 59 years, and one-time screening should be considered for all adults aged 18 years or older during travel preparation when relevant to routine care. CDC also says adults older than 40 years should receive a single hepatitis A vaccine dose as soon as travel is considered.
The CDC guidance gives specific intervals for typhoid vaccination and medicines. The oral Ty21a typhoid vaccine should be completed at least 24 hours before doxycycline use. It should be delayed for more than 72 hours after any antimicrobial agent, and antibiotics should not be given within 72 hours after the last Ty21a dose. The Vi capsular polysaccharide typhoid vaccine is a single 0.5 mL dose containing 25 micrograms, given at least 2 weeks before travel.
Yellow fever requirements also depend on itinerary. WHO recommends yellow fever vaccination for travelers aged 9 months or older going to areas with evidence of persistent or periodic transmission. WHO requires vaccination for travelers aged 9 months or older arriving from countries with a risk of yellow fever transmission, and for travelers transiting for more than 12 hours through an airport in a risk country.
The CDC notes that the cost of a pretravel consultation for a backpacker from the United States planning a 4-week trip to West Africa can exceed USD 1,000. That is a reported example for a specific traveler and itinerary, not a standard price for every consultation.
How trip length changes risk
A GeoSentinel study of long-term travelers found that the timing of return care was distributed across three periods: 32% returned in less than 1 week after travel, 38% returned 1–6 weeks after travel, and 30% returned more than 6 weeks after travel. Together, those periods describe when care occurred in that study population.
Compared with short-term travelers, long-term travelers had 1.20 times the odds of chronic diarrhea and 1.57 times the odds of giardiasis. They had 1.5 times the odds of Plasmodium falciparum malaria and 2.46 times the odds of Plasmodium vivax malaria. The study also reported 1.69 times the odds of postinfectious irritable bowel syndrome.
Several outcomes showed larger differences. Long-term travelers had 3.09 times the odds of fatigue lasting more than 1 month, 3.34 times the odds of eosinophilia, 4.89 times the odds of cutaneous leishmaniasis, 4.45 times the odds of unspecified schistosomiasis, and 3.33 times the odds of Entamoeba histolytica diarrhea.
Odds ratios compare groups; they are not percentages of travelers who became ill and do not mean that a condition is inevitable. The findings support paying attention to persistent symptoms after a prolonged itinerary, particularly when symptoms continue beyond the first days after return.
Business, leisure, and visiting-friends travelers
The GeoSentinel business-traveler analysis covered 10,567 non-expatriate business travelers and 12,080 total diagnoses from 1997 through 2014. Within the occupational-traveler group, 45% were business travelers, representing 4,174 of 9,248 people. Research or education travelers accounted for 19%, missionary travelers for 14%, travelers providing non-medical service work for 13%, and travelers providing medical care for 10%.
The same analysis found that 92% of non-occupational travelers were traveling for leisure and 8% were VFR travelers. Median ages differed by travel purpose: business travelers had a median age of 41 years; research or education travelers, 24 years; missionary travelers, 38 years; non-medical service travelers, 22 years; and medical-care travelers, 30 years.
These figures show why the phrase “international traveler” covers several different groups. A short leisure trip, a service placement, and repeated business travel can involve different durations, activities, and health preparation needs. The analysis measured travelers who came to care, not every person taking one of these trips.
Why planned and actual trips can differ
A prospective Boston-area family travel medicine study recorded 389 travelers presenting for pretravel consultation. Of these, 302 enrolled, or 77.6%. The study represented 101 unique itineraries. Post-travel surveys were received from 119 participants, or 39.4%, so the follow-up results apply to that responding group.
Among enrolled travelers, 73 were female, or 61%; 87, or 73%, were healthy; 84, or 71%, were Canadian-born; and 30, or 25.2%, were VFR travelers. Among returned travelers, 109, or 92%, reported discrepant trip experiences. Of those travelers, 68, or 62%, would have required alternative pretravel counseling.
The study’s result is a planning statistic rather than a disease rate. It indicates that the eventual experience often differed from the initial plan in that study population. It also explains why travel medicine specialists are particularly important for pregnant travelers and people with complicated health histories or prolonged itineraries, as noted in the CDC Yellow Book 2026.
For travelers, the practical implication is to share the most complete itinerary available, including transit and time away. WHO’s yellow fever transit rule and CDC’s medication timing guidance show how route details and departure dates can affect preparation. When plans change, the original consultation may no longer describe the trip that actually occurs.